-

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of National Vision Holdings, Inc. (EYE) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of National Vision Holdings, Inc. (“National Vision” or the “Company”) (NASDAQ: EYE) investors concerning the Company’s possible violations of federal securities laws.

On November 10, 2021, in connection with its third quarter 2021 financial results, National Vision tightened its fiscal 2021 sales outlook (but did not change its earnings guidance), indicating that the Company was suffering from a substantial deterioration in profit margins during fourth quarter 2021.

On this news, the Company’s stock price fell $8.30, or 13%, to close at $55.22 per share on November 10, 2021, thereby injuring investors.

Then, on May 9, 2022, National Vision issued its first quarter 2022 financial results, disclosing that the Company’s net revenues had decreased 1.2% to $527.7 million, its adjusted CSS had fallen 6.8%, net income had decreased 30.6% to $30.1 million, and its diluted EPS had decreased 28.2% to $0.34. The Company also adjusted its 2022 outlook, indicating that it was performing worse in terms of profits and earnings than before the pandemic.

On this news, National Vision’s stock price fell $8.34, or 25.7%, to close at $24.93 per share on May 10, 2022, thereby injuring investors further.

If you purchased National Vision securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

Law Offices of Howard G. Smith

NASDAQ:EYE

Release Versions

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

More News From Law Offices of Howard G. Smith

Law Offices of Howard G. Smith Encourages Soleno Therapeutics, Inc. (SLNO) Shareholders To Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ: SLNO) common stock between March 26, 2025 and November 4, 2026, inclusive (the “Class Period”). Soleno investors have until May 5, 2026 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN SOLENO THERAPEUTICS, INC. (SLNO), CONTACT THE LAW OFFICES OF HOWARD...

Law Offices of Howard G. Smith Encourages Camping World Holdings, Inc. (CWH) Shareholders to Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Camping World Holdings, Inc. (“Camping World” or the “Company”) (NYSE: CWH) securities between April 29, 2025 and February 24, 2026, inclusive (the “Class Period”). Camping World investors have until May 11, 2026 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CAMPING WORLD HOLDINGS, INC. (CWH), CONTACT THE LAW OF...

Deadline Approaching: Boston Scientific Corporation (BSX) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming May 4, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Boston Scientific Corporation (“Boston Scientific” or the “Company”) (NYSE: BSX) securities between July 23, 2025 and February 3, 2026, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN BOSTON SCIENTIFIC CORPORATION (BSX), CONTACT THE LAW OFFICES OF HOWARD G. SMITH...
Back to Newsroom